Integrated Diagnostics Inc.

Integrated Diagnostics is developing large-scale, blood-based molecular diagnostics that detect important diseases like lung cancer and Alzheimer's at their earliest stages by simultaneously monitoring tens to hundreds of disease markers. The company, founded in October 2009 by systems biology pioneer Dr. Lee Hood, is creating a new generation of personalized medical solutions using sophisticated informatics for biomarker selection and a novel class of synthetically created diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. Integrated Diagnostics' mission is to build a new generation of low-cost, large-scale diagnostic assays for early detection of serious diseases. The company is conceptually based on a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes, and other molecules. Investors include InterWest Partners, The Wellcome Trust, and BioTechCube Luxembourg. Foundational intellectual property is exclusively licensed from the Institute of Systems Biology and Caltech. *

	Start	2009-10-14 splitoff
	Industry	diagnostics (medical/biological)
	Industry 2	pharmacodiagnostic test (PDx)
	Person	Hood, Leroy (Institute for Systems Biology)
	Person 2	Luderer, Albert A. (Integrated Diagnostics 201003– CEO before BioTrove CEO before Ligth Sciences Inc before bioMérieux)

	Region	Seattle, WA
	Country	United States (USA)
	Street	401 Terry Ave N
	City	98109 Seattle, WA
	Tel	+1-206-732-2190
	Fax	+1-206-732-2199
		Address record changed: 2012-01-12

Basic data	Employees	n. a.

		* Document for »About Section«: Agilent Technologies Inc.. (1/10/12). "Press Release: Agilent Technologies and Integrated Diagnostics Enter Strategic Partnership to Develop Protein-based Assays for Early Disease Detection".

		Record changed: 2012-01-12

Follow Us!

Top News

Upcoming Events

Associations

Partners

Integrated Diagnostics Inc.

More documents for Integrated Diagnostics Inc.